FR2872708B1 - Dispositif de commande d'administration de principe actif - Google Patents

Dispositif de commande d'administration de principe actif

Info

Publication number
FR2872708B1
FR2872708B1 FR0507141A FR0507141A FR2872708B1 FR 2872708 B1 FR2872708 B1 FR 2872708B1 FR 0507141 A FR0507141 A FR 0507141A FR 0507141 A FR0507141 A FR 0507141A FR 2872708 B1 FR2872708 B1 FR 2872708B1
Authority
FR
France
Prior art keywords
active principle
control device
administration control
principle administration
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0507141A
Other languages
English (en)
Other versions
FR2872708A1 (fr
Inventor
Claus Bunke
Ralf Dittmann
Bernd Kaufmann
Jens Kohne
Jurgen Manigel
Gerald Panitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draegerwerk AG and Co KGaA
Original Assignee
Draeger Medical GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draeger Medical GmbH filed Critical Draeger Medical GmbH
Publication of FR2872708A1 publication Critical patent/FR2872708A1/fr
Application granted granted Critical
Publication of FR2872708B1 publication Critical patent/FR2872708B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Ce dispositif d'administration de principe actif permet de surveiller de façon simple la quantité de principe actif administré. Pour atteindre ce but, il est prévu un dispositif de sécurité (15) comprenant un modèle du profil du patient (16), permettant d'extrapoler, à partir des valeurs précédentes et actuelles de dosage du principe actif, une concentration future (17) en principe actif, qui arrête l'unité de dosage (10) en principe actif lorsque la concentration en principe actif (17) extrapolée dépasse une valeur limite (14) prédéterminée.
FR0507141A 2004-07-07 2005-07-05 Dispositif de commande d'administration de principe actif Expired - Fee Related FR2872708B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004032814.5A DE102004032814B4 (de) 2004-07-07 2004-07-07 Vorrichtung zur Steuerung der Wirkstoffzufuhr

Publications (2)

Publication Number Publication Date
FR2872708A1 FR2872708A1 (fr) 2006-01-13
FR2872708B1 true FR2872708B1 (fr) 2010-05-28

Family

ID=35517090

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0507141A Expired - Fee Related FR2872708B1 (fr) 2004-07-07 2005-07-05 Dispositif de commande d'administration de principe actif

Country Status (3)

Country Link
US (1) US7445609B2 (fr)
DE (1) DE102004032814B4 (fr)
FR (1) FR2872708B1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8116429B2 (en) 2009-01-29 2012-02-14 The Invention Science Fund I, Llc Diagnostic delivery service
US8130904B2 (en) 2009-01-29 2012-03-06 The Invention Science Fund I, Llc Diagnostic delivery service
US10458973B2 (en) 2010-12-22 2019-10-29 Roche Diabetes Care, Inc. Handheld diabetes management device with bolus calculator
US9849241B2 (en) 2013-04-24 2017-12-26 Fresenius Kabi Deutschland Gmbh Method of operating a control device for controlling an infusion device
JP2017086098A (ja) * 2014-03-20 2017-05-25 テルモ株式会社 送液ポンプ
DE102016007336B4 (de) 2016-06-16 2023-08-10 Drägerwerk AG & Co. KGaA Medizintechnische Vorrichtung und Verfahren zur Alarmorganisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3018641C2 (de) * 1980-05-16 1986-05-28 Hans 8228 Freilassing Rodler Automatische Infusionspumpe
US6572542B1 (en) * 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
DE20005004U1 (de) 2000-03-17 2000-06-08 B. Braun Melsungen Ag, 34212 Melsungen Narkoseregler
US6599281B1 (en) * 2000-05-03 2003-07-29 Aspect Medical Systems, Inc. System and method for adaptive drug delivery
US6631291B2 (en) * 2001-05-18 2003-10-07 Instrumentarium Corp. Closed loop drug administration method and apparatus using EEG complexity for control purposes
US6691043B2 (en) * 2001-08-28 2004-02-10 Maxi-Med, Llc Bolus calculator

Also Published As

Publication number Publication date
DE102004032814B4 (de) 2014-07-31
FR2872708A1 (fr) 2006-01-13
US20060009729A1 (en) 2006-01-12
DE102004032814A1 (de) 2006-02-02
US7445609B2 (en) 2008-11-04

Similar Documents

Publication Publication Date Title
FR2872708B1 (fr) Dispositif de commande d'administration de principe actif
US10905845B2 (en) Breathing apparatus detection and purging
US20190216377A1 (en) Devices and methods for monitoring oxygenation uring treatment with delivery of nitric oxide
JP6807409B2 (ja) 高濃度の一酸化窒素の投与法
NO971874D0 (no) Apparat for administrering av et medikamentfluid til en pasient
US11833299B2 (en) Clinical decision support system and methods
KR20170078814A (ko) 호흡기계 파라미터 유도식 자동 iv 투여 및 iv 관 클램프 작동
US20210308175A1 (en) Systems And Methods To Improve Organ Or Tissue Function And Organ Or Tissue Transplant Longevity
Eggert et al. Antidiuretic hormone regulation in patients with primary nocturnal enuresis.
Garrod et al. Evaluation of pulsed dose oxygen delivery during exercise in patients with severe chronic obstructive pulmonary disease
WO2015157524A1 (fr) Systèmes et procédés de distribution d'oxyde nitrique en concentration élevée
Maleki et al. Renal Blood Flow Response to Angiotensin 1‐7 versus Hypertonic Sodium Chloride 7.5% Administration after Acute Hemorrhagic Shock in Rats
Gilpin et al. Effects of neuropeptide Y and ethanol on arousal and anxiety-like behavior in alcohol-preferring rats
CN113081351B (zh) 一种智能清新口气的装置及方法
CN204972673U (zh) 用于治疗人肺动脉高压的给药系统
Mertz-Nielsen et al. Reappraisal of bicarbonate secretion by the human oesophagus.
Bellgardt et al. Mortality and recovery after inhalational compared to intravenous ICU sedation: A-809
FR3136986A1 (fr) Affichage de la dose de NO par un dispositif de fourniture de NO en phase de pause
Trainer et al. Quantitative growth hormone secretion and final adult height
Hvistendahl et al. Reduced renal vascular resistance in response to verapamil during gradated ureter obstruction in pigs
Paul et al. Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: A-832

Legal Events

Date Code Title Description
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 11

TP Transmission of property

Owner name: DRAGERWERK AG & CO. KGAA, DE

Effective date: 20160226

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

ST Notification of lapse

Effective date: 20240305